X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (223) 223
acth-secreting pituitary adenoma - pathology (165) 165
female (156) 156
index medicus (155) 155
male (135) 135
endocrinology & metabolism (128) 128
adult (120) 120
adenoma - pathology (115) 115
middle aged (105) 105
acth-secreting pituitary adenoma - surgery (90) 90
pituitary neoplasms - pathology (80) 80
tumors (73) 73
magnetic resonance imaging (69) 69
aged (68) 68
adenoma - surgery (67) 67
surgery (64) 64
acth (55) 55
cushing's disease (53) 53
adolescent (51) 51
acth-secreting pituitary adenoma - complications (49) 49
young adult (49) 49
cushings-disease (46) 46
pituitary acth hypersecretion - pathology (45) 45
treatment outcome (45) 45
acth-secreting pituitary adenoma - diagnosis (43) 43
acth-secreting pituitary adenoma - metabolism (43) 43
pituitary (42) 42
adenoma - complications (41) 41
pituitary adenoma (41) 41
retrospective studies (40) 40
medicine & public health (39) 39
transsphenoidal surgery (39) 39
clinical neurology (38) 38
pituitary acth hypersecretion - surgery (38) 38
immunohistochemistry (37) 37
pituitary neoplasms - surgery (37) 37
adenomas (36) 36
acth-secreting pituitary adenoma - genetics (32) 32
adenoma (32) 32
adenoma - metabolism (32) 32
adrenocorticotropic hormone (31) 31
expression (31) 31
pituitary gland - pathology (31) 31
diabetes (30) 30
acth-secreting pituitary adenoma - drug therapy (29) 29
diagnosis (29) 29
management (29) 29
adenoma - diagnosis (27) 27
adenoma - genetics (25) 25
disease (25) 25
pituitary acth hypersecretion - etiology (25) 25
abridged index medicus (24) 24
adrenocorticotropic hormone - blood (24) 24
neurosurgery (24) 24
prolactinoma - pathology (24) 24
animals (23) 23
child (23) 23
pituitary acth hypersecretion - diagnosis (23) 23
gland (22) 22
pituitary neoplasms - metabolism (22) 22
pituitary-adenomas (22) 22
remission induction (21) 21
endocrinology (20) 20
pituitary gland (20) 20
carcinoma (19) 19
pathology (19) 19
cushing disease (18) 18
pituitary acth hypersecretion - complications (18) 18
pituitary gland tumors (18) 18
adenoma - drug therapy (17) 17
adrenocorticotropic hormone - secretion (17) 17
cancer (17) 17
follow-up studies (17) 17
hydrocortisone - blood (17) 17
adrenalectomy (16) 16
growth hormone-secreting pituitary adenoma - pathology (16) 16
recurrence (16) 16
cells (15) 15
cushings-syndrome (15) 15
nervous system diseases (15) 15
pituitary neoplasms - genetics (15) 15
temozolomide (15) 15
cushing syndrome (14) 14
cushing’s disease (14) 14
experience (14) 14
health aspects (14) 14
human physiology (14) 14
oncology (14) 14
pituitary acth hypersecretion - drug therapy (14) 14
prognosis (14) 14
tomography, x-ray computed (14) 14
cushing syndrome - etiology (13) 13
endocrine system (13) 13
microsurgery (13) 13
neoplasm invasiveness (13) 13
pituitary neoplasms - diagnosis (13) 13
remission (13) 13
acth-secreting pituitary adenoma - blood (12) 12
acth-secreting pituitary adenoma - therapy (12) 12
adrenocorticotropic hormone - metabolism (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Endocrinology, ISSN 0022-0795, 2016, Volume 231, Issue 2, pp. 135 - 145
Somatostatin analogs (SSA) are the mainstay of pharmacological treatment for pituitary adenomas. However, some patients escape from therapy with octreotide, a... 
Somatostatin | Gene expression | Pituitary | Cell signaling | Pituitary adenoma | pituitary | SOMATOSTATIN ANALOG SOM230 | AGGRESSIVE FEATURES | MEDICAL-TREATMENT | CUSHINGS-DISEASE | QUANTITATIVE-ANALYSIS | pituitary adenoma | RECEPTOR SUBTYPES | GROWTH-HORMONE | somatostatin | cell signaling | ENDOCRINOLOGY & METABOLISM | ACTH RELEASE | gene expression | ADENOMAS | GENE-EXPRESSION LEVELS | ACTH-Secreting Pituitary Adenoma - drug therapy | Humans | Drug Resistance, Neoplasm | Male | Pituitary Gland - secretion | Somatostatin - pharmacology | Prolactinoma - metabolism | Receptors, Somatostatin - genetics | Antineoplastic Agents, Hormonal - adverse effects | Growth Hormone-Secreting Pituitary Adenoma - metabolism | Pituitary Neoplasms - secretion | Receptors, Somatostatin - metabolism | Neoplasm Proteins - genetics | Prolactinoma - pathology | Cell Survival - drug effects | Pituitary Neoplasms - drug therapy | ACTH-Secreting Pituitary Adenoma - secretion | Calcium Signaling - drug effects | Adenoma - secretion | Growth Hormone-Secreting Pituitary Adenoma - pathology | Pituitary Gland - metabolism | Somatostatin - adverse effects | Prolactinoma - secretion | Neoplasm Proteins - metabolism | Adenoma - metabolism | Receptors, Somatostatin - agonists | Protein Isoforms - metabolism | Protein Isoforms - agonists | Adenoma - drug therapy | Female | Gene Expression Regulation, Neoplastic - drug effects | Tumor Cells, Cultured | Prolactinoma - drug therapy | Somatostatin - analogs & derivatives | Antineoplastic Agents, Hormonal - pharmacology | ACTH-Secreting Pituitary Adenoma - metabolism | Pituitary Gland - pathology | Cells, Cultured | Octreotide - adverse effects | Pituitary Neoplasms - pathology | Pituitary Neoplasms - metabolism | Octreotide - pharmacology | Growth Hormone-Secreting Pituitary Adenoma - drug therapy | Neoplasm Proteins - agonists | Adenoma - pathology | Growth Hormone-Secreting Pituitary Adenoma - secretion | ACTH-Secreting Pituitary Adenoma - pathology | Pituitary Gland - drug effects | Protein Isoforms - genetics
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 10/2010, Volume 95, Issue 10, pp. 4592 - 4599
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 08/2017, Volume 102, Issue 8, pp. 2836 - 2843
Journal Article
Journal Article
Journal Article
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 06/2017, Volume 176, Issue 6, pp. 769 - 777
Objectives: Only few retrospective studies have reported an efficacy rate of temozolomide (TMZ) in pituitary tumors (PT), all around 50%. However, the... 
RESISTANT | DIAGNOSIS | MANAGEMENT | THERAPY | PROTEIN | ENDOCRINOLOGY & METABOLISM | MGMT PROMOTER METHYLATION | EXPERIENCE | PRIMARY BRAIN | ADENOMAS | ACTH-Secreting Pituitary Adenoma - drug therapy | ACTH-Secreting Pituitary Adenoma - prevention & control | Follow-Up Studies | Dacarbazine - therapeutic use | Tumor Burden - radiation effects | Humans | Drug Resistance, Neoplasm | Male | Practice Patterns, Physicians | Chemoradiotherapy | Prolactinoma - prevention & control | Prolactinoma - radiotherapy | Neoplasm Recurrence, Local - pathology | Neoplasm Grading | Dacarbazine - analogs & derivatives | Adult | Female | Pituitary Neoplasms - radiotherapy | Retrospective Studies | Carcinoma - pathology | France | Prolactinoma - drug therapy | Pituitary Neoplasms - prevention & control | Prolactinoma - pathology | ACTH-Secreting Pituitary Adenoma - radiotherapy | Carcinoma - drug therapy | Neoplasm Recurrence, Local - prevention & control | Neoplasm Invasiveness | Carcinoma - prevention & control | Pituitary Neoplasms - pathology | Carcinoma - radiotherapy | Antineoplastic Agents, Alkylating - therapeutic use | Pituitary Neoplasms - drug therapy | Tumor Burden - drug effects | Survival Analysis | Neoplasm Recurrence, Local - epidemiology | Temozolomide | ACTH-Secreting Pituitary Adenoma - pathology | Cohort Studies | Carcinoma | Brain tumors | Pituitary | Standardization | Radiation therapy | Survival | Patients | Tumors
Journal Article
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 02/2016, Volume 174, Issue 2, pp. 213 - 226
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 2013, Volume 169, Issue 3, pp. 329 - 337
Journal Article
World Neurosurgery, ISSN 1878-8750, 2017, Volume 104, pp. 1048.e1 - 1048.e7
Background Rathke cleft cysts (RCCs) and pituitary adenomas (PAs) are thought to have a common embryonic ancestry; however, PAs with a concomitant RCC inside... 
Neurosurgery | Rathke cleft cyst | Ectopic pituitary adenoma | Clival invasion | Sphenoid sinus tumor | ACTH pituitary adenoma | SURGERY | RESECTION | HYPERPROLACTINEMIA | SELLA | GLAND | LESIONS | CLINICAL NEUROLOGY | Neoplasms, Multiple Primary - surgery | Sphenoid Sinus - pathology | Adenoma - surgery | Choristoma - diagnostic imaging | Paranasal Sinus Neoplasms - diagnostic imaging | Humans | Tomography, X-Ray Computed | ACTH-Secreting Pituitary Adenoma - diagnostic imaging | Neoplasms, Multiple Primary - diagnostic imaging | ACTH-Secreting Pituitary Adenoma - complications | Sphenoid Sinus - diagnostic imaging | Paranasal Sinus Neoplasms - surgery | Paranasal Sinus Diseases - diagnostic imaging | Adenoma - complications | ACTH-Secreting Pituitary Adenoma - surgery | Adenoma - diagnostic imaging | Choristoma - complications | Female | Paranasal Sinus Diseases - pathology | Paranasal Sinus Diseases - complications | Sphenoid Sinus - surgery | Choristoma - surgery | Central Nervous System Cysts - surgery | Central Nervous System Cysts - diagnostic imaging | Neoplasms, Multiple Primary - pathology | Paranasal Sinus Neoplasms - complications | Central Nervous System Cysts - pathology | Magnetic Resonance Imaging | Paranasal Sinus Neoplasms - pathology | Adenoma - pathology | Central Nervous System Cysts - complications | Paranasal Sinus Diseases - surgery | Aged | Choristoma - pathology | Pituitary Gland | ACTH-Secreting Pituitary Adenoma - pathology | ACTH | Pituitary gland tumors | Adenoma
Journal Article
Journal Article
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 03/2016, Volume 174, Issue 3, pp. 307 - 314
Background: Ki-67 labeling index (LI) is currently regarded as a useful prognostic marker of pituitary adenoma (PA) clinical behavior, although its relevance... 
KI-67 | MCM PROTEINS | P53 EXPRESSION | CYCLIN D1 | MIB-1 | ENDOCRINOLOGY & METABOLISM | LABELING INDEX | PROLIFERATION INDEX | CLINICAL BEHAVIOR | CANCER | DNA-REPLICATION | Immunohistochemistry | Prognosis | Humans | Middle Aged |